Engelsk

Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulär  
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
pht003439
Beskrivning

pht003439

Alias
UMLS CUI [1,1]
C3846158
Subject ID
Beskrivning

SUBJECT_ID

Datatyp

text

Alias
UMLS CUI [1,1]
C2348585
Sample ID
Beskrivning

SAMPLE_ID

Datatyp

text

Alias
UMLS CUI [1,1]
C1299222
Sample source
Beskrivning

SAMPLE_SOURCE

Datatyp

text

Alias
UMLS CUI [1,1]
C0449416
UMLS CUI [1,2]
C2347026
Source sample ID
Beskrivning

SOURCE_SAMPLE_ID

Datatyp

text

Alias
UMLS CUI [1,1]
C1299222
UMLS CUI [1,2]
C0449416
Sample Use
Beskrivning

SAMPLE_USE

Datatyp

text

Alias
UMLS CUI [1,1]
C2347026
UMLS CUI [1,2]
C1524063
DbGaP top-level (parent) study and/or sub-study accession: phs000640 parent study, phs000642 sub-study, phs000643 sub-study, phs000665 sub-study, phs001010 sub-study, phs001029 sub-study, phs001268 sub-study, phs001269 sub-study, phs001450 sub-study, phs001520 sub-study, phs001671 sub-study, phs001669 sub-study, phs001944 sub-study.
Beskrivning

STUDY

Datatyp

text

Alias
UMLS CUI [1,1]
C1527178
UMLS CUI [1,2]
C0947630
UMLS CUI [2,1]
C0332283
UMLS CUI [2,2]
C0947630
Tillbaka till toppen

Similar models

Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.

18 Formulär
  1. StudyEvent: SEV1
    1. Subject ID, subject source, source subject ID, consent group, and affection status of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    2. Subject ID, sample ID, sample source, source sample ID, study, and sample use variable of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    3. Sample ID, analyte type, and tumor status of a participant with uterine cervical neoplasm and involved in the "The Haplotype-Resolved Genome and Epigenome of the Aneuploid HeLa Cancer Cell Line" project.
    4. Sample ID, analyte type, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "The Genomic and Transcriptomic Landscape of a HeLa Cell Line" project.
    5. Subject ID, birthplace, sex, and race of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    6. Sample ID and trace ID of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    7. Sample ID, body site where sample was collected, analyte type, histological type and sequences center of a participant with uterine cervical neoplasms and involved in the "HeLa S3 (CCL-2.2) HiC Sequencing" project.
    8. Sample ID, body site where sample was obtained, analyte type, tumor status, histological type of sample, primary or metastatic tumor, sequencing center of participant with uterine cervical adenocarcinoma and involved in the "High Resolution Maps of the HeLa 3D Genome Using Hi-C" project.
    9. Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, primary or metastatic tumor, primary tumor location, and sequencing center of participant with uterine cervical adenocarcinoma and involved in the "The Heterogeneity Study of HeLa S3 Cells Based on Full-Length Single-Cell RNA-seq" project.
    10. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Construction of Thousands of Single Cell Genome Sequencing Libraries Using Combinatorial Indexing" project.
    11. Sample ID, analyte type, body site where sample was obtained, genotyping center, and tumor status of sample obtained from a participant with uterine cervical neoplasm and involved in the "Massively Multiplex Single-Cell Hi-C of HeLa Cells" project.
    12. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of participants uterine cervical neoplasm and involved in the "Identification of G-quadruplex Clusters by High-throughput Sequencing of Whole-genome Amplified Products with a G-quadruplex Ligand" project.
    13. Sample ID and GEO accession of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    14. Sample ID, analyte type, body site where sample was obtained, tumor status of sample, and sequencing center of participants with or without gastrointestinal cancer and involved in the "Gastrointestinal Cancer Treatment Responders" project.
    15. Sample ID, experimental conditions, tumor sample status, type of sample data, and source where sample was sequenced of a participant with uterine cervical neoplasm and involved in the "Examination of engineered LINE-1 Integration events in HeLa cells" project.
    16. Sample ID, analyte type, body site where sample was obtained, histological type of sample, and tumor status of sample of a participant with uterine cervical neoplasm and involved in the "RNA Ligation Precedes U6 snRNA/LINE-1 Retrotransposition" project.
    17. Sample ID, analyte type, body site where sample was obtained, histological type of sample, tumor status of sample, primary or metastatic tumor, primary tumor location, and sequencing center of a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
    18. Sample ID, tumor status of sample, and histological type of sample obtained from a participant with uterine cervical neoplasm and involved in the "HeLa Cell Genome Sequencing Studies" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
pht003439
C3846158 (UMLS CUI [1,1])
SUBJECT_ID
Item
Subject ID
text
C2348585 (UMLS CUI [1,1])
SAMPLE_ID
Item
Sample ID
text
C1299222 (UMLS CUI [1,1])
SAMPLE_SOURCE
Item
Sample source
text
C0449416 (UMLS CUI [1,1])
C2347026 (UMLS CUI [1,2])
SOURCE_SAMPLE_ID
Item
Source sample ID
text
C1299222 (UMLS CUI [1,1])
C0449416 (UMLS CUI [1,2])
SAMPLE_USE
Item
Sample Use
text
C2347026 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
STUDY
Item
DbGaP top-level (parent) study and/or sub-study accession: phs000640 parent study, phs000642 sub-study, phs000643 sub-study, phs000665 sub-study, phs001010 sub-study, phs001029 sub-study, phs001268 sub-study, phs001269 sub-study, phs001450 sub-study, phs001520 sub-study, phs001671 sub-study, phs001669 sub-study, phs001944 sub-study.
text
C1527178 (UMLS CUI [1,1])
C0947630 (UMLS CUI [1,2])
C0332283 (UMLS CUI [2,1])
C0947630 (UMLS CUI [2,2])
Tillbaka till toppen